Effect of hemorheological parameters on myocardial injury after primary or elective percutaneous coronary intervention

被引:9
|
作者
Fracassi, Francesco [1 ]
Vetrugno, Vincenzo [1 ]
Mandurino-Mirizzi, Alessandro [1 ]
Cosentino, Nicola [1 ]
Panicale, Serena [2 ]
Caprari, Patrizia [2 ]
Niccoli, Giampaolo [1 ]
Crea, Filippo [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Inst Cardiol, Largo Francesco Vito 8, I-00168 Rome, Italy
[2] Italian Natl Inst Hlth, Rome, Italy
关键词
blood viscosity; coronary angioplasty; hemorheology; microvascular obstruction; periprocedural necrosis; WHOLE-BLOOD VISCOSITY; ST-SEGMENT ELEVATION; SLOW-FLOW; INFARCTION; AGGREGATION; REPERFUSION; RISK; DYSFUNCTION; GUIDELINES; PLASMA;
D O I
10.1097/MCA.0000000000000661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAbnormal blood viscosity favors atherosclerosis owing to endothelial dysfunction and changes in shear stress. Its effect on coronary microvasculature during percutaneous coronary intervention (PCI) is still unknown. We aimed to investigate the role of hemorheological parameters in the incidence of microvascular obstruction (MVO) and the periprocedural necrosis after primary or elective PCI, and secondarily, we evaluated their prognostic significance.Materials and methodsWe enrolled 25 patients with ST-elevation myocardial infarction (STEMI), 30 patients with non-ST-elevation myocardial infarction (NSTEMI), and 30 patients with stable angina (SA) undergoing PCI. MVO in patients with STEMI and periprocedural necrosis in patients with NSTEMI and those with SA were assessed using angiographic/electrocardiographic and laboratory methods, respectively. Hemorheological profile included blood viscosity () at shear rates 200s(-1) and 1s(-1), the erythrocyte aggregation index ((1)/(200)), and plasma viscosity. Major adverse cardiovascular events occurrence was evaluated at follow-up.ResultsPatients with STEMI experiencing angiographic MVO (28%) had higher (200) (5.421.28 vs. 3.98 +/- 1.22mPa.s; P=0.015). Similarly, patients with STEMI experiencing electrocardiographic MVO (56%) had higher (200) (4.58 +/- 0.36 vs. 3.94 +/- 0.19mPa.s; P<0.001). Among patients with SA and patients with NSTEMI, those experiencing periprocedural necrosis (23.3%) had higher (200) (5.30 +/- 0.86 vs. 4.37 +/- 0.88mPa.s; P=0.001), (1) (19.52 +/- 9.62 vs. 13.29 +/- 7.65mPa.s; P=0.015) and (1)/(200) values (3.64 +/- 1.50 vs. 2.72 +/- 0.92; P=0.007). These significant differences were maintained after adjustment for age, sex, and cardiovascular risk factors. At follow-up (30 +/- 6 months), 25 (29.4%) patients presented major adverse cardiovascular events, and they had higher (200) (5.18 +/- 1.00 vs. 4.25 +/- 1.01mPa.s; P<0.001).ConclusionIn patients undergoing either urgent or elective PCI, hemorheological parameters might contribute to myocardial injury and, if furtherly confirmed, to an unfavorable outcome.
引用
收藏
页码:638 / 646
页数:9
相关论文
共 50 条
  • [31] Does trimetazidine prevent myocardial injury after percutaneous coronary intervention?
    Marzilli, Mario
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2008, 5 (01): : 16 - 17
  • [32] Does trimetazidine prevent myocardial injury after percutaneous coronary intervention?
    Mario Marzilli
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 : 16 - 17
  • [33] Management of patients after primary percutaneous coronary intervention for myocardial infarction
    Dalal, Fatima
    Dalal, Hasnain M.
    Voukalis, Christos
    Gandhi, Manish M.
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 358
  • [34] Association of preprocedural low-density Lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention
    Li, Xiao-Lin
    Li, Jian-Jun
    Guo, Yuan-Lin
    Zhu, Cheng-Gang
    Xu, Rui-Xia
    Li, Sha
    Qing, Ping
    Wu, Na-Qiong
    Jiang, Li-Xin
    Xu, Bo
    Gao, Run-Lin
    JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (04) : 423 - 432
  • [35] Relation of myocardial perfusion to mortality after primary percutaneous coronary intervention
    Karha, J
    Excire, JE
    Rajagopal, V
    Ivanc, TB
    Kapadia, SR
    Ellis, SG
    Brener, SJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (08): : 980 - 982
  • [36] Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?
    Cuculi, F.
    Lim, C. C. S.
    Banning, A. P.
    HEART, 2010, 96 (10) : 736 - 740
  • [37] Pharmacological preconditioning by Nicorandil in prevention of ischaemic myocardial injury during an elective percutaneous coronary intervention
    Soboleva, G.
    Gostishev, R., V
    Rogoza, A. N.
    Kotkina, T., I
    Samko, A. N.
    Soboleva, T., V
    Karpov, V. A.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1463 - 1463
  • [38] Can prasugrel decrease the extent of periprocedural myocardial injury during elective percutaneous coronary intervention?
    Tomaniak, Mariusz
    Koltowski, Lukasz
    Kochman, Janusz
    Huczek, Zenon
    Rdzanek, Adam
    Pietrasik, Arkadiusz
    Gasecka, Aleksandra
    Gajda, Sylwia
    Opolski, Grzegorz
    Filipiak, Krzysztof J.
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (11): : 730 - 740
  • [39] The effect of smoking status on outcomes after primary percutaneous coronary intervention for acute myocardial infarction
    Chowdhury, PS
    Harjai, KJ
    Boura, JA
    Grines, LL
    CIRCULATION, 2002, 106 (19) : 445 - 446
  • [40] Effect of Vitamin D in the Prevention of Myocardial Injury Following Elective Percutaneous Coronary Intervention: A Pilot Randomized Clinical Trial
    Aslanabadi, Naser
    Jafaripor, Iraj
    Sadeghi, Selda
    Hamishehkar, Hadi
    Ghaffari, Samad
    Toluey, Mehdi
    Azizi, Hanieh
    Entezari-Maleki, Taher
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (02): : 144 - 151